v3.26.1
Summary of significant accounting policies (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Jun. 30, 2025
Jun. 30, 2024
Jan. 08, 2026
Jul. 01, 2022
Jun. 01, 2022
Current liabilities $ 590 $ 10,590   $ 10,590            
Cash for operating activities                
Net losses (590) (10,000)                
Accumulated deficit $ (590) (10,590)   (10,590)            
Common stock, shares authorized 100                  
Common stock, par value $ 0.0001                  
Common stock, shares issued 100                  
Common stock, shares outstanding 100                  
Exascale Labs Inc. [Member]                    
Cash and cash equivalents   984,830   984,830   $ 4,231,689 $ 969,626      
Current liabilities   29,153,918   29,153,918   20,319,721 9,881,828      
Cash for operating activities       (3,758,611) $ (757,960) (1,010,799) (560,909)      
Net losses   (2,632,431) $ (1,537,059) (7,916,977) (6,178,537) (7,659,667) (4,956,347)      
Accumulated deficit   (21,134,012)   (21,134,012)   (13,217,035) (5,557,368)      
Cash equivalents   0   0   0 0      
Refundable deposits receivable   510,000   510,000   681,125 110,000      
Allowance for expected credit losses   0   0   0 0      
Impairment of long-lived assets       0 0 0 0      
Revenue   $ 3,754,586 $ 1,862,158 10,561,331 4,475,885 7,015,512 1,319,115      
Revenue recognized       366,075 95,326 95,326 0      
Advertising and promotion expenses       $ 32,113 76,090 $ 157,388 $ 26,340      
Common stock, shares authorized   1,500   1,500   1,500 1,500 1,500   1,500
Common stock, par value   $ 0.01   $ 0.01   $ 0.01 $ 0.01   $ 0.01  
Common stock, shares issued           1,500 1,500      
Common stock, shares outstanding           1,500 1,500      
Dividends       $ 0 $ 0 $ 0 $ 0      
Cash and cash equivalents and U.S. Dollar Coin   $ 5,100,000   5,100,000            
Receipt of digital assets   644,616   939,397            
Disbursement of digital assets   796,781   939,397            
Fair value gain or loss on digital assets   0   0            
Deferred offering costs   95,000   95,000   (0)        
Amortization of prepaid research and development costs   625,000   1,875,000            
Other receivables   0   0   1,207,626 2,884,694      
Refundable deposits payable   $ 1,174,702   $ 1,174,702   $ 1,445,580 $ 223,205      
Exascale Labs Inc. [Member] | Class A Ordinary Shares [Member]                    
Common stock, shares authorized   303   303       303    
Common stock, par value   $ 0.01   $ 0.01            
Common stock, shares issued   303   303            
Common stock, shares outstanding   303   303            
Exascale Labs Inc. [Member] | Class B Ordinary Shares [Member]                    
Common stock, shares authorized   1,197   1,197       1,197    
Common stock, par value   $ 0.01   $ 0.01            
Common stock, shares issued   1,197   1,197            
Common stock, shares outstanding   1,197   1,197